Location History:
- Tokyo, JP (1995 - 1999)
- Marburg, DE (1992 - 2007)
Company Filing History:
5 out of 66 
3 out of 340 
2 out of 57 Years Active: 1992-2007
Title: The Innovative Contributions of Egon Amann
Introduction
Egon Amann, a distinguished inventor based in Marburg, Germany, has made significant strides in the field of genetic engineering and biotechnology. With an impressive portfolio of 12 patents, he has contributed to advancements that enhance our understanding and treatment of genetic disorders related to coagulation factors.
Latest Patents
Among his latest innovations, Amann has developed methods for the preparation of factor XIIIa through gene manipulation. In this groundbreaking patent, the complementary DNA (cDNA) that encodes factor XIIIa was isolated using a cDNA bank derived from human placenta. This innovation not only enables the production of high-purity factor XIIIa but also facilitates the creation of diagnostic aids for analyzing genetic defects associated with factor XIIIa. Moreover, the work allows for the development of antibodies suitable for diagnostic purposes and antibody columns, enhancing the diagnostic toolkit for healthcare professionals.
Another key patent involves the preparation of DNA encoding factor XIIIa, again utilizing the cDNA bank from human placenta. This research echoes the earlier patent, underscoring Amann's commitment to harnessing genetic manipulation techniques for both therapeutic and diagnostic applications.
Career Highlights
Throughout his career, Amann has collaborated with notable companies such as Hoechst Japan Limited and Behringwerke Aktiengesellschaft. His work at these institutions has allowed him to push the boundaries of biotechnology and apply his research in practical settings.
Collaborations
Egon Amann has had the privilege of working alongside esteemed colleagues like Sunao Takeshita and Ulrich Grundmann. These collaborations have further enriched his innovations and provided a platform for exchanging ideas and knowledge within the field.
Conclusion
Egon Amann's contributions to biotechnology, particularly in the area of coagulation factors, exemplify the importance of innovation in medical research. His patents not only advance scientific understanding but also pave the way for improved diagnostic and therapeutic tools. As the field of genetic engineering continues to evolve, the impact of inventors like Amann will be felt for years to come.